{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T18:39:36Z","timestamp":1767724776580,"version":"build-2238731810"},"update-to":[{"DOI":"10.1002\/14651858.cd003224","type":"withdrawal","label":"Withdrawal","source":"publisher","updated":{"date-parts":[[2001,7,23]],"date-time":"2001-07-23T00:00:00Z","timestamp":995846400000}}],"reference-count":27,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd003224.pub2","type":"journal-article","created":{"date-parts":[[2007,1,25]],"date-time":"2007-01-25T08:35:23Z","timestamp":1169714123000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Eletriptan for acute migraine"],"prefix":"10.1002","author":[{"given":"Lesley A","family":"Smith","sequence":"first","affiliation":[{"name":"Oxford Brookes University; Department of Psychology, Social Work and Public Health; Jack Straws Lane Marston Oxford UK OX3 0FL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Oldman","sequence":"additional","affiliation":[{"name":"University of Oxford; Pain Research and Nuffield Department of Anaesthetics; West Wing (Level 6) John Radcliffe Hospital Oxford UK OX3 9DU"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry J","family":"McQuay","sequence":"additional","affiliation":[{"name":"University of Oxford; Pain Research and Nuffield Department of Clinical Neurosciences (Nuffield Division of Anaesthetics); West Wing (Level 6) John Radcliffe Hospital Oxford Oxfordshire UK OX3 9DU"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R Andrew","family":"Moore","sequence":"additional","affiliation":[{"name":"Plymouth UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheena","family":"Derry","sequence":"additional","affiliation":[{"name":"Oxford Oxfordshire UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,7,23]]},"reference":[{"key":"10.1002\/14651858.CD003224.pub2-BIB1|cit1","unstructured":"Pfizer Inc A double-blind, randomised, placebo-controlled, parallel-group study of the efficacy and safety of eletriptan and Cafergot when given for the treatment of acute migraine 1999. Data on file. Protocol 160-307"},{"key":"10.1002\/14651858.CD003224.pub2-BIB2|cit2","unstructured":"Pfizer Inc A multicenter, double-blind, double-dummy, parallel-group, placebo-controlled, dose-response study of oral UK-116,044 (eletriptan) and oral sumatriptan (100 mg) given for the acute treatment of migraine (with and without aura) 1999. Data on file. Protocol 160-314"},{"key":"10.1002\/14651858.CD003224.pub2-BIB3|cit3","unstructured":"Pfizer Inc A multicenter, double-blind, double-dummy, parallel-group, placebo-controlled study of two dose levels of oral eletriptan and two dose levels of oral sumatriptan given for the acute treatment of migraine 1999. Data on file. Protocol 160-318"},{"key":"10.1002\/14651858.CD003224.pub2-BIB4|cit4","unstructured":"Pfizer Inc A multicenter, double-blind, placebo-controlled, parallel-group study of two dose levels of oral eletriptan and two dose levels of oral sumatriptan given for the acute treatment of migraine 1999. Data on file. Protocol 160-104"},{"key":"10.1002\/14651858.CD003224.pub2-BIB5|cit5","unstructured":"Pfizer Inc A multicentre, double-blind, randomised, parallel-group, placebo-controlled study to assess the safety and efficacy of two oral dose levels of eletriptan given for the acute treatment of migraine 1999. Data on file. Protocol 160-305"},{"key":"10.1002\/14651858.CD003224.pub2-BIB6|cit6","unstructured":"Pfizer Inc A multicentre, double-blind, randomised, placebo-controlled, parallel-group study of the efficacy and safety of oral eletriptan in subjects with acute migraine 1999. Data on file. Protocol 160-102"},{"key":"10.1002\/14651858.CD003224.pub2-BIB7|cit7","unstructured":"Pfizer Inc A multicenter, double-blind, randomised, placebo-controlled, parallel-group study of the efficacy and safety of escalating the dose of oral eletriptan in subjects with acute migraine 1999. Data on file. Protocol 160-103 (same as Pfizer 1999g, under 'Excluded studies')"},{"key":"10.1002\/14651858.CD003224.pub2-BIB8|cit8","unstructured":"Pfizer Inc A multicenter, double-blind, randomised, placebo-controlled, parallel-group study of the efficacy and safety of escalating the dose of oral eletriptan in subjects with acute migraine 1999. Data on file. Protocol 160-103 (same as Pfizer [AEs only], under 'Included studies')"},{"issue":"10","key":"10.1002\/14651858.CD003224.pub2-BIB9|cit9","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1111\/j.1742-1241.2000.tb10954.x","article-title":"Pharmacology and efficacy of eletriptan for the treatment of migraine attacks","volume":"54","author":"Diener","year":"2000","journal-title":"Int J Clin Pract"},{"issue":"1","key":"10.1002\/14651858.CD003224.pub2-BIB10|cit10","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1212\/WNL.54.1.156","article-title":"Eletriptan in acute migraine: a double-blind, placebo-controlled comparison to sumatriptan. Eletriptan Steering Committee","volume":"54","author":"Goadsby","year":"2000","journal-title":"Neurology"},{"issue":"6","key":"10.1002\/14651858.CD003224.pub2-BIB11|cit11","doi-asserted-by":"crossref","first-page":"557","DOI":"10.2165\/00019053-200018060-00003","article-title":"Effectiveness of eletriptan in reducing time loss caused by migraine attacks","volume":"18","author":"Wells","year":"2000","journal-title":"Pharmacoeconomics"},{"issue":"6977","key":"10.1002\/14651858.CD003224.pub2-BIB12|cit12","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1136\/bmj.310.6977.452","article-title":"The number needed to treat: a clinically useful measure of treatment effect [published erratum appears in BMJ 1995;310(6986):1056]","volume":"310","author":"Cook","year":"1995","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD003224.pub2-BIB13|cit13","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1185\/03007999909116495","article-title":"The UK migraine patient survey: quality of life and treatment","volume":"15","author":"Dowson","year":"1999","journal-title":"Current Medical Research & Opinion"},{"key":"10.1002\/14651858.CD003224.pub2-BIB14|cit14","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1177\/0333102499019S2302","article-title":"How to assess and compare drugs in the management of migraine: success rates in terms of response and recurrence","volume":"19 Suppl 23","author":"Ferrari","year":"1999","journal-title":"Cephalalgia"},{"issue":"6522","key":"10.1002\/14651858.CD003224.pub2-BIB15|cit15","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1136\/bmj.292.6522.746","article-title":"Confidence intervals rather than P values: estimation rather than hypothesis testing","volume":"292","author":"Gardner","year":"1986","journal-title":"BMJ"},{"issue":"3","key":"10.1002\/14651858.CD003224.pub2-BIB16|cit16","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0304-3959(99)00302-4","article-title":"An evaluation of homogeneity tests in meta-analyses in pain using simulations of individual patient data","volume":"85","author":"Gavaghan","year":"2000","journal-title":"Pain"},{"issue":"8","key":"10.1002\/14651858.CD003224.pub2-BIB17|cit17","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/archinte.159.8.813","article-title":"Burden of migraine in the United States: disability and economic costs","volume":"159","author":"Hu","year":"1999","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD003224.pub2-BIB18|cit18","first-page":"1","article-title":"Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain","volume":"8 Suppl 7","year":"1988","journal-title":"Cephalagia"},{"issue":"1","key":"10.1002\/14651858.CD003224.pub2-BIB19|cit19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1468-2982.1991.1101001.x","article-title":"Guidelines for controlled trials of drugs in migraine. First edition","volume":"11","year":"1991","journal-title":"Cephalalgia"},{"issue":"1","key":"10.1002\/14651858.CD003224.pub2-BIB20|cit20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Controlled Clinical Trials"},{"issue":"6 Suppl 3","key":"10.1002\/14651858.CD003224.pub2-BIB21|cit21","first-page":"S6","article-title":"Migraine in the United States: a review of epidemiology and health care use","volume":"43","author":"Lipton","year":"1993","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD003224.pub2-BIB22|cit22","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1111\/j.1526-4610.1999.00006.x","article-title":"Acute migraine therapy: do doctors understand what patients with migraine want from therapy?","volume":"39 Suppl 2","author":"Lipton","year":"1999","journal-title":"Headache"},{"issue":"3","key":"10.1002\/14651858.CD003224.pub2-BIB23|cit23","article-title":"Rizatriptan for acute migraine (Cochrane Review)","author":"Oldman","year":"2001","journal-title":"The Cochrane Library"},{"key":"10.1002\/14651858.CD003224.pub2-BIB24|cit24","unstructured":"Oldman AO Smith LA McQuay HJ Moore RA A systematic review of treatments for acute migraine Submitted to Pain"},{"key":"10.1002\/14651858.CD003224.pub2-BIB25|cit25","first-page":"159","article-title":"Migraine and headache: a meta-analytic approach","volume-title":"Epidemiology of pain","author":"Scher","year":"1999"},{"issue":"8","key":"10.1002\/14651858.CD003224.pub2-BIB26|cit26","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1046\/j.1468-2982.1998.1808532.x","article-title":"Efficacy and adverse events of subcutaneous, oral, and intranasal sumatriptan used for migraine treatment: a systematic review based on number needed to treat","volume":"18","author":"Tfelt-Hansen","year":"1998","journal-title":"Cephalalgia"},{"issue":"7109","key":"10.1002\/14651858.CD003224.pub2-BIB27|cit27","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1136\/bmj.315.7109.635","article-title":"Impact of covert duplicate publication on meta-analysis: a case study","volume":"315","author":"Tramer","year":"1997","journal-title":"BMJ"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD003224.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T10:24:55Z","timestamp":1683714295000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD003224.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Pain, Palliative and Supportive Care Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2001,7,23]]},"references-count":27,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd003224.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,7,23]]}}}